Overview
Imax Q2 revenue of $91.7 mln beats analyst expectations
Adjusted EPS of $0.26 surpasses estimates, reflecting strong performance
IMAX box office grows 41% YoY, boosting net income 139%
Outlook
Company says Q3 off to a very strong start
Co expects record $1.2 bln global box office in 2025
IMAX confident in network growth and content slate performance
Result Drivers
NETWORK GROWTH - IMAX reports 50% YoY increase in system installations, driving network growth
BOX OFFICE SURGE - 41% YoY increase in IMAX box office revenue boosts net income margins
TECHNOLOGY ADOPTION - Record number of releases filmed with IMAX technology increases market share
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $91.70 mln | $91.20 mln (12 Analysts) |
Q2 Adjusted EPS | Beat | $0.26 | $0.21 (10 Analysts) |
Q2 EPS | $0.2 | ||
Q2 Adjusted Net Income | Beat | $14.60 mln | $11.20 mln (5 Analysts) |
Q2 Net Income | $12.20 mln | ||
Q2 Gross Margin | 58.5% | ||
Q2 Adjusted EBITDA Margin | 42.6% |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the entertainment production peer group is "buy"
Wall Street's median 12-month price target for Imax Corp is $32.00, about 9.3% above its July 23 closing price of $29.03
Press Release: ID:nBwbMW1gsa
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.